As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
|Articles|October 11, 2010
- Volume 0 0
TEST TITLE
Author(s)TEST
Advertisement
TEST
Articles in this issue
over 18 years ago
Gout: A Big Pain in the Big Toeover 18 years ago
can you READ these Rxs?over 18 years ago
Case Studiesover 18 years ago
ASTHMA WATCHover 18 years ago
CHOLESTEROL WATCHover 18 years ago
ARTHRITIS WATCHover 18 years ago
DIABETES WATCHover 18 years ago
WOMEN'S HEALTH WATCHover 18 years ago
pharmacy TECHNOLOGY productsover 18 years ago
compounding HOTLINENewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Could CAR T Therapy Become Adjustable After Infusion?
2
The Value of Self-Monitoring Blood Glucose Tools in Preventing and Reducing Prediabetes and Diabetes-Related Complications
3
Lp(a), PREVENT, and LDL-C Goals: Insights From NLA Fall Update
4
Using CKDintercept to Build Interdisciplinary Kidney Care
5